Erasca, INC.(ERAS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ERAS Erasca, INC.

未开盘 11-10 16:00:00 EST

15.48

-0.13

-0.83%

盘后15.62

+0.14+0.90%

19:58 EST

最高15.67	最低15.00	成交量598.50万
今开15.43	昨收15.61	日振幅4.26%
总市值54.14亿	流通市值46.97亿	总股本3.50亿
成交额9,209万	换手率1.97%	流通股本3.03亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ERAS","market":"US","secType":"STK","nameCN":"Erasca, INC.","latestPrice":15.48,"timestamp":1794344400000,"preClose":15.61,"halted":0,"volume":5985045,"hourTrading":{"tag":"盘后","latestPrice":15.62,"preClose":15.48,"latestTime":"19:58 EST","volume":73241,"amount":1133850.0018,"timestamp":1794358704182,"change":0.14,"changeRate":0.009044,"amplitude":0.009044},"delay":0,"changeRate":-0.008327994875080014,"floatShares":303453585,"shares":349762000,"eps":-0.970994,"marketStatus":"未开盘","change":-0.13,"latestTime":"11-10 16:00:00 EST","open":15.43,"high":15.665,"low":15,"amount":92094730.311375,"amplitude":0.042601,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.970994,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1794387600000},"marketStatusCode":0,"adr":0,"listingDate":1626408000000,"exchange":"NASDAQ","adjPreClose":15.61,"preHourTrading":{"tag":"盘前","latestPrice":15.42,"preClose":15.61,"latestTime":"09:29 EST","volume":1960,"amount":30175.01536,"timestamp":1794320999999,"change":-0.19,"changeRate":-0.012172,"amplitude":0.070468},"postHourTrading":{"tag":"盘后","latestPrice":15.62,"preClose":15.48,"latestTime":"19:58 EST","volume":73241,"amount":1133850.0018,"timestamp":1794358704182,"change":0.14,"changeRate":0.009044,"amplitude":0.009044},"volumeRatio":1.316904,"impliedVol":1.316,"impliedVolPercentile":0.8486},"requestUrl":"/m/hq/s/ERAS","defaultTab":"news","newsList":[{"id":"1185916118","title":"Erasca计划针对ERAS-0015在胰腺癌和肺癌领域开展三项可能支持注册的关键性试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1185916118","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1185916118?lang=zh_cn&edition=full","pubTime":"2026-08-24 20:03","pubTimestamp":1787573033,"startTime":"0","endTime":"0","summary":"Erasca公司宣布，其计划针对候选药物ERAS-0015启动三项可能支持注册的关键性临床试验，适应症覆盖胰腺癌和肺癌领域。此举标志着该公司在肿瘤治疗管线推进上迈出重要一步，显示出其对这一候选药物的战略布局和临床开发决心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ERAS","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186350763","title":"Erasca获FDA快速通道认定：泛Ras分子胶Eras-0015进军转移性胰腺癌治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1186350763","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1186350763?lang=zh_cn&edition=full","pubTime":"2026-08-24 20:01","pubTimestamp":1787572917,"startTime":"0","endTime":"0","summary":"生物医药领域再传重磅消息——Erasca公司宣布，其自主研发的泛Ras分子胶候选药物Eras-0015，已成功获得美国食品药品监督管理局授予的快速通道认定。这一认定针对的适应症，正是临床需求极为迫切的转移性胰腺导管腺癌。获得这一资格，不仅肯定了Eras-0015在临床前及早期临床研究中展现出的潜力，也为其后续的注册路径铺平了道路。胰腺癌治疗格局正面临深刻重塑。而Eras-0015，正是这一探索浪潮中的最新弄潮儿。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ERAS","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145327228","title":"新闻稿：Erasca 依据纳斯达克上市规则第5635(c)(4)条授予激励性股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1145327228","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1145327228?lang=zh_cn&edition=full","pubTime":"2026-08-11 04:03","pubTimestamp":1786392238,"startTime":"0","endTime":"0","summary":"该股票期权于2026年8月10日授予，行权价格定为授予当日Erasca普通股在纳斯达克全球精选市场上的收盘价。根据纳斯达克上市规则第5635条，此项激励计划专门用于向此前并非Erasca员工、或经历一段真正的非雇佣期后，作为其入职Erasca的重要诱因而授予股权奖励的个人。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDX","QQQY","TECS","JEPQ","QID","QLD","PSQ","ERAS","QDTE","TQQY","QQQA","MNQmain","BK4539","BK4139","QYLG","QQQ","ONEQ","SQQQ","IYW",".IXIC","QQQE","QQQJ","TQQQ","FTEC","QQQM","GPIQ","NVIW.SI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123280089","title":"异动解读｜Erasca盘中下跌5.27%，6.325亿美元扩大股票发行完成引发稀释担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1123280089","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1123280089?lang=zh_cn&edition=full","pubTime":"2026-07-16 23:57","pubTimestamp":1784217434,"startTime":"0","endTime":"0","summary":"7月16日，Erasca盘中下跌5.27%，报20.14美元/股，成交额3885.03万美元。该发行规模较最初计划的5亿美元显著扩大，且发行价格低于当前交易价，市场对大额股权稀释的担忧成为股价承压的主要因素。Erasca是一家临床阶段精准肿瘤学公司，专注于为RAS/MAPK通路驱动的癌症患者发现、开发和商业化疗法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ERAS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175483649","title":"异动解读｜Erasca盘中上涨5.41%，积极临床数据及注册推进计划提振市场信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1175483649","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175483649?lang=zh_cn&edition=full","pubTime":"2026-07-15 22:40","pubTimestamp":1784126419,"startTime":"0","endTime":"0","summary":"7月15日，Erasca盘中上涨5.41%，报20.58美元/股，成交额4289.97万美元。尽管公司同日宣布拟公开发行5亿美元普通股，盘后一度因稀释担忧下跌3.5%，但积极的临床进展及明确的注册路径显著提振了市场对公司长期价值的信心，推动股价在次日交易时段走强。Erasca是一家临床阶段精准肿瘤学公司，专注于为RAS/MAPK通路驱动的癌症患者发现、开发和商业化疗法。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ERAS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124567538","title":"Erasca盘后股价下挫3.5%，拟公开发行5亿美元普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1124567538","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124567538?lang=zh_cn&edition=full","pubTime":"2026-07-14 04:40","pubTimestamp":1783975244,"startTime":"0","endTime":"0","summary":"生物科技公司Erasca股价在盘后交易时段下跌3.5%。公司于同日宣布，计划通过公开发行筹集高达5亿美元的资金，发行标的为普通股。此项融资提案旨在为公司运营及管线开发提供资金支持。市场对股权稀释的担忧，或是导致股价在消息公布后应声走低的主要原因。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ERAS","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171279469","title":"Erasca计划在2027年上半年启动支持注册的肺癌试验；胰腺癌III期试验定于2027年","url":"https://stock-news.laohu8.com/highlight/detail?id=1171279469","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1171279469?lang=zh_cn&edition=full","pubTime":"2026-07-14 04:05","pubTimestamp":1783973115,"startTime":"0","endTime":"0","summary":"Erasca公司宣布了其临床开发管线的重要规划。该公司计划在2027年上半年启动一项旨在支持新药注册的肺癌临床试验。此外，针对胰腺癌的III期关键性试验也已提上日程，预计将在2027年展开。\n这两项试验的推进标志着Erasca在肿瘤治疗领域的研究进入了新的阶段。肺癌和胰腺癌均是全球范围内发病率和死亡率较高的癌症类型，存在巨大的未满足医疗需求。公司此举旨在通过临床研究，为患者带来新的治疗希望。\n具体试验设计、患者招募标准以及详细的实施时间表，预计将在后续适时公布。行业观察者正密切关注Erasca的研发进展，这些试验结果可能对未来癌症治疗格局产生影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","ERAS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140568937","title":"Erasca公布潜在最优级泛Ras分子胶Eras-0015在Kras突变实体瘤中的更新初步一期数据及注册推进计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1140568937","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1140568937?lang=zh_cn&edition=full","pubTime":"2026-07-14 04:02","pubTimestamp":1783972937,"startTime":"0","endTime":"0","summary":"Erasca公司今日宣布，针对其潜在最优级的泛Ras分子胶药物Eras-0015，在治疗Kras突变实体瘤方面，已公布了更新的初步一期临床试验数据，并同步披露了旨在推动该药物实现注册上市的关键计划。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","ERAS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155239287","title":"异动解读｜Erasca盘中上涨9.64%，报11.315美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1155239287","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1155239287?lang=zh_cn&edition=full","pubTime":"2026-05-21 00:13","pubTimestamp":1779293612,"startTime":"0","endTime":"0","summary":"5月21日，Erasca盘中上涨9.64%，报11.315美元/股，成交额3731.19万美元。Erasca所在的生物科技行业中，个股中，HCW Biologics涨96.24%，Immunovant涨33.66%，Roivant Sciences涨14.34%，安进跌0.01%，艾伯维公司跌0.61%。Erasca是一家临床阶段的精准肿瘤学公司，专注于发现、开发和商业化RAS/MAPK通路驱动癌症患者的疗法，旨在创造新的疗法和联合方案以全面关闭RAS/MAPK通路治疗癌症。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ERAS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148385071","title":"Erasca宣布与默克达成临床试验合作与供应协议，共同评估Eras-0015联合Keytruda®（帕博利珠单抗）的疗效","url":"https://stock-news.laohu8.com/highlight/detail?id=1148385071","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1148385071?lang=zh_cn&edition=full","pubTime":"2026-05-11 19:01","pubTimestamp":1778497277,"startTime":"0","endTime":"0","summary":"Erasca公司已正式宣布，其与默克公司达成了一项临床试验合作与供应协议。根据该协议，双方将共同开展临床研究，以评估Erasca旗下在研药物Eras-0015与默克的明星产品Keytruda®（通用名：帕博利珠单抗）联合使用的潜力。此项合作旨在探索该联合疗法在相关适应症中的安全性与有效性，标志着两家公司在肿瘤治疗领域研发合作的重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ERAS","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518020919","title":"Erasca, Inc.盘中异动 股价大跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518020919","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518020919?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:08","pubTimestamp":1741630106,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日02时08分，Erasca, Inc.股票出现波动，股价快速下跌5.23%。截至发稿，该股报1.45美元/股，成交量100.523万股，换手率0.36%，振幅6.86%。Erasca, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。Erasca, Inc.公司简介：Erasca Inc 是一家临床阶段的精准肿瘤学公司，专注于为 RAS / MAPK 通路驱动的癌症患者发现、开发和商业化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311020826a26a8b47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311020826a26a8b47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ERAS","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517192340","title":"Erasca, Inc.盘中异动 下午盘股价大涨6.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517192340","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517192340?lang=zh_cn&edition=full","pubTime":"2025-03-06 03:12","pubTimestamp":1741201932,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日03时12分，Erasca, Inc.股票出现异动，股价急速拉升6.82%。截至发稿，该股报1.41美元/股，成交量73.6654万股，换手率0.26%，振幅4.92%。Erasca, Inc.股票所在的生物技术行业中，整体涨幅为2.10%。Erasca, Inc.公司简介：Erasca Inc 是一家临床阶段的精准肿瘤学公司，专注于为 RAS / MAPK 通路驱动的癌症患者发现、开发和商业化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306031213989d820a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306031213989d820a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","ERAS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516308036","title":"Erasca, Inc.盘中异动 大幅跳水5.11%报1.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516308036","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516308036?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:13","pubTimestamp":1741014785,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时13分，Erasca, Inc.股票出现波动，股价急速跳水5.11%。截至发稿，该股报1.30美元/股，成交量16.6855万股，换手率0.06%，振幅8.39%。Erasca, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。Erasca, Inc.公司简介：Erasca Inc 是一家临床阶段的精准肿瘤学公司，专注于为 RAS / MAPK 通路驱动的癌症患者发现、开发和商业化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303231305989a1b88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303231305989a1b88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","ERAS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514375368","title":"Erasca, Inc.盘中异动 早盘股价大涨5.04%报1.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514375368","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514375368?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:00","pubTimestamp":1740754842,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时00分，Erasca, Inc.股票出现异动，股价快速拉升5.04%。截至发稿，该股报1.36美元/股，成交量7.2151万股，换手率0.03%，振幅5.04%。Erasca, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Erasca, Inc.公司简介：Erasca Inc 是一家临床阶段的精准肿瘤学公司，专注于为 RAS / MAPK 通路驱动的癌症患者发现、开发和商业化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228230042a25808b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228230042a25808b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ERAS","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514733913","title":"Erasca, Inc.盘中异动 下午盘快速下挫5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514733913","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514733913?lang=zh_cn&edition=full","pubTime":"2025-02-28 03:01","pubTimestamp":1740682881,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日03时01分，Erasca, Inc.股票出现异动，股价急速下挫5.04%。Erasca, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Quoin Pharmaceuticals Ltd涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1882.38%、321.37%、149.41%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pds Biotechnology Corporation、Pepgen Inc.，振幅分别为86.14%、55.84%、52.94%。Erasca, Inc.公司简介：Erasca Inc 是一家临床阶段的精准肿瘤学公司，专注于为 RAS / MAPK 通路驱动的癌症患者发现、开发和商业化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228030123989541f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228030123989541f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ERAS","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514156048","title":"Erasca, Inc.盘中异动 下午盘急速下跌5.32%报1.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514156048","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514156048?lang=zh_cn&edition=full","pubTime":"2025-02-26 02:57","pubTimestamp":1740509824,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日02时57分，Erasca, Inc.股票出现波动，股价大幅下挫5.32%。截至发稿，该股报1.34美元/股，成交量44.8279万股，换手率0.16%，振幅8.51%。Erasca, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Erasca, Inc.公司简介：Erasca Inc 是一家临床阶段的精准肿瘤学公司，专注于为 RAS / MAPK 通路驱动的癌症患者发现、开发和商业化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022602570498927f44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022602570498927f44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","ERAS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512352834","title":"Erasca, Inc.盘中异动 股价大跌5.81%报1.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512352834","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512352834?lang=zh_cn&edition=full","pubTime":"2025-02-20 03:14","pubTimestamp":1739992483,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日03时14分，Erasca, Inc.股票出现波动，股价急速下跌5.81%。截至发稿，该股报1.46美元/股，成交量42.3583万股，换手率0.15%，振幅5.81%。Erasca, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。Erasca, Inc.公司简介：Erasca Inc 是一家临床阶段的精准肿瘤学公司，专注于为 RAS / MAPK 通路驱动的癌症患者发现、开发和商业化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220031444988b5de5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220031444988b5de5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ERAS","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511696493","title":"Erasca, Inc.盘中异动 快速上涨5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511696493","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511696493?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:31","pubTimestamp":1739543477,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时31分，Erasca, Inc.股票出现异动，股价快速拉升5.52%。Erasca, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。其相关个股中，Virpax Pharmaceuticals, Inc.、Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Virpax Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为987.87%、354.42%、318.30%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Theratechnologies Inc.、Virpax Pharmaceuticals, Inc.，振幅分别为20.20%、18.33%、15.20%。Erasca, Inc.公司简介：Erasca Inc 是一家临床阶段的精准肿瘤学公司，专注于为 RAS / MAPK 通路驱动的癌症患者发现、开发和商业化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223117abcf0627&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223117abcf0627&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ERAS","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510380892","title":"Erasca, Inc.盘中异动 早盘快速下挫5.18%报1.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510380892","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510380892?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:37","pubTimestamp":1739284635,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时37分，Erasca, Inc.股票出现异动，股价大幅跳水5.18%。截至发稿，该股报1.56美元/股，成交量3.6265万股，换手率0.01%，振幅6.10%。Erasca, Inc.股票所在的生物技术行业中，整体跌幅为0.91%。Erasca, Inc.公司简介：Erasca Inc 是一家临床阶段的精准肿瘤学公司，专注于为 RAS / MAPK 通路驱动的癌症患者发现、开发和商业化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223716a241fc74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223716a241fc74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","ERAS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510894191","title":"Erasca, Inc.盘中异动 急速上涨5.03%报1.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510894191","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510894191?lang=zh_cn&edition=full","pubTime":"2025-02-11 03:52","pubTimestamp":1739217151,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日03时52分，Erasca, Inc.股票出现波动，股价急速拉升5.03%。截至发稿，该股报1.67美元/股，成交量122.646万股，换手率0.43%，振幅3.77%。Erasca, Inc.股票所在的生物技术行业中，整体跌幅为0.96%。Erasca, Inc.公司简介：Erasca Inc 是一家临床阶段的精准肿瘤学公司，专注于为 RAS / MAPK 通路驱动的癌症患者发现、开发和商业化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211035231961e3b35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211035231961e3b35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ERAS","BK4539"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.erasca.com","stockEarnings":[{"period":"1week","weight":0.0574},{"period":"1month","weight":-0.0343},{"period":"3month","weight":-0.1668},{"period":"6month","weight":0.4928},{"period":"1year","weight":5.7598},{"period":"ytd","weight":3.1613}],"compareEarnings":[{"period":"1week","weight":-0.0059},{"period":"1month","weight":-0.0368},{"period":"3month","weight":-0.0292},{"period":"6month","weight":0.0023},{"period":"1year","weight":0.1005},{"period":"ytd","weight":0.0997}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Erasca, Inc.于2018年7月2日在特拉华州注册成立。该公司是一家临床阶段的精准肿瘤学公司，专注于发现、开发和商业化RAS/MAPK通路驱动癌症患者的疗法。该公司由精准肿瘤学和RAS靶向领域的领先先驱共同创立，旨在创造新的疗法和联合方案，旨在全面关闭RAS/MAPK通路以治疗癌症。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":0.210192},{"month":2,"riseRate":0.6,"avgChangeRate":0.079229},{"month":3,"riseRate":0.2,"avgChangeRate":-0.084063},{"month":4,"riseRate":0.2,"avgChangeRate":-0.107381},{"month":5,"riseRate":0.4,"avgChangeRate":0.028932},{"month":6,"riseRate":0.6,"avgChangeRate":0.063313},{"month":7,"riseRate":0.6,"avgChangeRate":0.149968},{"month":8,"riseRate":0.5,"avgChangeRate":0.054674},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.055676},{"month":10,"riseRate":0.5,"avgChangeRate":0.031638},{"month":11,"riseRate":0.5,"avgChangeRate":-0.021778},{"month":12,"riseRate":0.6,"avgChangeRate":-0.005114}],"exchange":"NASDAQ","name":"Erasca, INC.","nameEN":"Erasca, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Erasca, INC.(ERAS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Erasca, INC.(ERAS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Erasca, INC.,ERAS,Erasca, INC.股票,Erasca, INC.股票老虎,Erasca, INC.股票老虎国际,Erasca, INC.行情,Erasca, INC.股票行情,Erasca, INC.股价,Erasca, INC.股市,Erasca, INC.股票价格,Erasca, INC.股票交易,Erasca, INC.股票购买,Erasca, INC.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Erasca, INC.(ERAS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Erasca, INC.(ERAS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}